A tale of two cities: a comparison of sarcoidosis in London and New York.
D000328:Adult; D000367:Age Factors; D044383:Black People; D002738:Chloroquine / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005132:Eye Manifestations; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000209:etiology; D008131:London; D008171:Lung Diseases / Q000175:diagnosis; D008198:Lymph Nodes; D008297:Male; D009461:Neurologic Manifestations; D009518:New York; D010113:Oxyphenbutazone / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D011658:Pulmonary Fibrosis / Q000209:etiology; D013902:Radiography, Thoracic; D012129:Respiratory Function Tests; D012131:Respiratory Insufficiency; D012469:Salivary Glands; D012507:Sarcoidosis / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000401:mortality / Q000473:pathology; D012712:Serum Globulins; D012737:Sex Factors; D012877:Skin Manifestations; D014374:Tuberculin Test; D014397:Tuberculosis, Pulmonary / Q000175:diagnosis; D044465:White People; D001741:Black or African American
D012712:Serum Globulins; D002738:Chloroquine; D011239:Prednisolone; D010113:Oxyphenbutazone